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Cytosolic Intermediates for Cell Wall
Biosynthesis and Degradation Control Inducible
b-Lactam Resistance in Gram-Negative Bacteria
Christine Jacobs,*² Jean-Marie FreÁ re,* that must be strictly controlled to allow cell growth while
avoiding lysis, owing to a deregulation of these poten-and Staffan Normark²
tially suicidal hydrolytic activities. Bacteria can sense*Centre d'IngeÂ nierie des ProteÂ ines
perturbations in their cell wall metabolism and translateUniversiteÂ de LieÁ ge
the resulting stress into signals that induce defensiveInstitut de Chimie
responses. Penicillins and other b-lactam antibiotics in-BaÃ timent B6
duce such perturbations, and bacteria have evolved var-Sart-Tilman, B-4000 LieÁ ge 1
ious defense mechanisms against these agents, amongBelgium
which b-lactamase production is the most common.²Microbiology and Tumorbiology Center
In many gram-negative bacteria, the presence ofKarolinska Institutet
b-lactam antibiotics in the medium induces the synthe-S-17177 Stockholm
sis of the chromosome-encoded AmpC b-lactamaseSweden
(Normark et al., 1994). The inducible ampC b-lactamase
gene is transcriptionally controlled by the divergently
read regulator gene, ampR (Lindberg et al., 1985). AmpRSummary
belongs to the large LysR family of bacterial regulators
(Henikoff et al., 1988). Like many other members of this
b-lactam induction of chromosomal b-lactamase in family, AmpR has two regulatory properties: in cells
gram-negative bacteria requires the transcriptional grown in the presence of b-lactam antibiotic inducers,
regulator AmpR and the transport of murein break- AmpR activates ampC while it represses the transcrip-
down products (muropeptides) into the cytoplasm. In tion of its own gene in both the presence and absence
vitro transcription shows that purified AmpR acts as of b-lactam inducers (Lindquist et al., 1989). Knockout
an activator for ampC b-lactamase synthesis. The mu- mutations in another locus, ampD, which encodes a
rein precursor, UDP-MurNAc-pentapeptide, decreases cytosolic protein, result in constitutive hyperproduction
AmpR-mediated transcriptional activation in vitro, but of AmpC b-lactamase (Lindberg et al., 1987). SuchampD
has no effect on an AmpR(G102E) mutant that medi- mutants are considerably more resistant than wild±type
ates constitutive activation of ampC in vivo. Addition inducible strains to many b-lactamase-stable b-lactam
of the muropeptide, anhMurNAc-tripeptide, which ac- antibiotics. b-lactamase induction also requires a cyto-
cumulates in b-lactamase-overproducing mutants, plasmic membrane protein encoded by ampG. In the
counteracts the negative effect of UDP-MurNAc-pen- absence of AmpG, no induction occurs (Korfmann and
tapeptide, restoring the innate ability of AmpR to in- Sanders, 1989), and no constitutive activation of ampC
duce ampC expression in vitro. Cytosolic intermedi- takes place in ampG±ampD double mutants (Lindquist
ates of murein biosynthesis and degradation thus act et al., 1993).
In gram-negative bacteria such as E. coli, approxi-antagonistically to control b-lactamase expression,
mately 50% of A2pm-containing material is liberatedthereby operating as a cell±wall sensing device.
from the murein at each generation, but most of these
fragments (muropeptides) are back-transported into theIntroduction
cytoplasm and recycled for further murein biosynthesis
(Goodell, 1985). In addition to modified b-lactamase reg-The murein (or peptidoglycan) isan essential component
ulation, ampD and ampG E. coli mutants have also lostof the bacterial cell wall that protects the cell from os-
the ability to recycle muropeptides. This clearly demon-motic lysis and determines its shape. The basic murein
strates an intimate link between b-lactamase inductionsubunit of gram-negative bacteria is an N-acetylglu-
and murein recycling (Jacobs et al., 1994), which is de-
cosamine (GlcNAc)-N-acetylmuramic acid (MurNAc)
scribed by Figure 1.
disaccharide, with a short L-alanyl-g-D-glutamyl-meso-
b-lactamase induction appears to be regulated by the
diaminopimelyl-D-alanine (L-Ala-D-Glu-m-A2pm-D-Ala) level of a muropeptide(s) in the cytoplasm, since ampD
peptide amide-linked to the carboxyl group of the Mur- mutants with derepressed b-lactamase production ac-
NAc residue. The assembly of the disaccharide-peptide cumulate large quantities of 1,6-anhydro MurNAc-L-Ala-
unit takes place both in the cytoplasm and on the mem- D-Glu-m-A2pm (anhMurNAc-tripeptide) in their cyto-
brane (van Heijenoort, 1994). The six cytoplasmic uridine plasm (Jacobs et al., 1994). Moreover, in wild-type cells,
nucleotide precursors are formed by sequential reac- the intracellular concentration of muropeptides also in-
tions catalyzed by specific synthetases from uridine py- creases upon addition of the b-lactamase inducer cefox-
rophosphoryl (UDP)-GlcNAc to UDP-MurNAc-L-Ala-D- itin, although not as sharply as in ampD mutants (Jacobs
Glu-m-A2pm-D-Ala-D-Ala (UDP-MurNAc-pentapeptide). et al., 1994). Consequently, the working model implies
In the periplasm, the E. coli murein is continuously that the recycled anhMurNAc-tripeptide and possibly
remodeled as the bacterium grows and divides. The the GlcNAc-anhMurNAc-tripeptide could act as endog-
expansion of the wall and the formation of the septa enous signals for transcriptional induction of b-lacta-
involve the action of periplasmic hydrolases that create mase production. A second consequence of cefoxitin
sites for the insertion of new subunits (HoÈ ltje and Tuoma- exposure, however, is a significant decrease of thecellu-
nen, 1991). The integrity of the wall rests on a dynamic lar level of the murein precursor UDP-MurNAc-penta-
peptide (Jacobs et al., 1994), suggesting that the mureinbalance between synthetic and degradation activities
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Figure 1. Interconnected Pathway of AmpC b-lactamase Induction
and Murein Recycling
Figure 2. Overproduction and Purification of Wild-Type and Mutant
The cell wall murein is degraded by specific cell wall hydrolases to (G102E) AmpR Proteins
yield GlcNAc-anhMurNAc-tripeptide (GlcaMurTp). This muropeptide
(A) The overproduction and purification of wild-type AmpR and Am-is presumably transported into the cytoplasm by the specificperme-
pR(G102E) were monitored by SDS±PAGE. Lane 1, E. coliase AmpG and the GlcNAc residue removed by the cytosolic
BL21(DE3)/pCJ2 cells before IPTG induction; lanes 2 and 3, E. coliN-b-acetylglucosaminidase. The resulting anhMurNAc-tripeptide
BL21(DE3) cells harboring pCJ2 (lane 2) or pCJ3 (lane 3) after IPTG(aMurTp) is hydrolyzed by the cytosolic amidase AmpD to release
induction; lane 4, insoluble protein fraction after cell disruption;tripeptide (Tp) (HoÈ ltje et al., 1994; Jacobs et al., 1995). The formed
lane 5, soluble protein fraction after solubilization of AmpR-enrichedtripeptide (Tp) is then reintroduced into the murein biosynthetic
aggregates with 2 M GdnHCl and dialysis against a Tris-HCl bufferpathway by direct addition to the murein precursor UDP-MurNAc.
containing 0.5M NaCl; lane 6, soluble protein fraction after precipita-This last step is catalyzed by the murein tripeptide ligase Mpl (Men-
tion in Tris-HCl buffer containing 0.05 M NaCl; lane 7, soluble proteingin-Lecreulx et al., 1996). Inactivation of ampG or ampD abolishes
fraction after solubilization of the precipitate with 2 M GdnHCl andthis recycling process. In addition to the murein recycling, AmpG
dialysis against the Tris-HCl buffer containing 0.5 M NaCl; lane 8,and AmpD are also essential components of the inducible AmpC
protein fraction after molecular sieve chromatography in Tris-HCl
b-lactamase system. In ampG mutants, ampC expression is nonin-
buffer containing 0.5 M NaCl and protein concentration. The arrow-ducible and remains at a low basal level, whereas ampD deletion
head shows bands with the predicted AmpR size. The position ofmutants overexpress AmpC independently of b-lactam antibiotic.
the molecular mass standards (kilodaltons) are shown on the left.Since inactivation of ampD also results in an intracellular accumula-
(B) The active fraction of the purified wild-type AmpR preparationtion of the AmpD substrate, anhMurNAc-tripeptide (aMurTp), this
was determined by using a DNA±affinity beads procedure. Themuropeptide could act as an endogenous signaling effector of
amount of free AmpR after magnetic separation of the beads wasAmpR-mediated transcriptional induction of AmpC production.
determined by Western blot analysis. Lane 1, after incubation with
DNA-coated beads; lane 2, after incubation with beads free of target
DNA; lane 3, after washing the DNA-coated beads in Tris-HCl buffer;
biosynthesis pathway might also participate in b-lacta- lane 4, after washing the beads free of target DNA in Tris-HCl buffer;
lane 5, after resuspension of DNA-coated beads in Tris-HCl buf-mase induction.
fer containing 2 M NaCl; lane 6, after resuspension of beads free ofThe aim of this study was to investigate directly the
target DNA in Tris-HCl buffer containing 2 M NaCl. The arrowheadpotential interactions of the transcriptional regulator
shows the position of AmpR.
AmpR with intermediates of the degradative and/or bio-
synthetic pathways of murein metabolism.
lane 8). The active fraction of this purified AmpR prepa-
ration was estimated by its ability to bind DNA. Biotinyl-Results
ated DNA fragments harboring the AmpR-specific rec-
ognition sequence were attached to streptavidin-coatedAmpR Activates ampC Transcription In Vitro
in the Absence of Added Factors magnetic beads. The purified AmpR was incubated with
the resulting magnetic DNA affinity beads using a nearlyTo elucidate the signaling mechanism underlying AmpC
b-lactamase induction, the transcriptional regulator saturating ratio of AmpR to immobilized DNA(see Exper-
imental Procedures). As a control, the same amount ofAmpR was purified to protein homogeneity, and its abil-
ity to activate transcription in vitro in the presence or AmpR was incubated with beads devoid of target DNA.
After magnetic separation, the amount of AmpR proteinabsence of murein metabolites was studied.
Overproduction of AmpR was obtained by cloning that remained in the soluble fraction was determined by
Western immunoblot analysis. As shown in Figure 2Bthe ampR gene in the pET-9a expression vector (see
Experimental Procedures). The resulting pCJ2 plasmid (lane 1), no AmpR could be detected after incubation
with the DNA-coated beads while it remained in thedirected high level synthesis of AmpR after IPTG induc-
tion (Figure 2A, lanes 1 and 2). After cell disruption, most soluble fraction with beads devoid of target DNA (Figure
2B, lane 2). After washing the beads, the bound AmpRof the overproduced AmpR protein was sequestered in
the insoluble fraction of the cellular extract from which proteins could be eluted by resuspending the DNA-
coated beads in a buffer of high ionic strength (FigureAmpR was purified (Figure 2A, lane 4) by two rounds of
protein denaturation/renaturation (Figure 2A, lanes 5±7) 2B, lane 5). The purified AmpR preparation (shown in
Figure 2A, lane 8) was thus fully active.and a final molecular sieve chromatography (Figure 2A,
b-Lactam Resistance and Cell Wall Metabolism
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in vitro-generated transcripts, as determined by the
lengths of the primer-extension products, agreed with
those observed in vivo (Normark et al., 1994) and as
described for the control tet gene (BalbaÂs et al., 1986).
In vitro repression of ampR transcription by AmpR is
consistent with the observation that AmpR negatively
regulates its own expression in vivo (Lindquist et al.,
1989) by binding to an operator sequence that overlaps
the ampR promoter (Figure 5A). However, the observa-
tion that purified AmpR in the absence of activating
ligands stimulated transcription of ampC was surprising,
since AmpR alone is not sufficient for activating ampC
expression in vivo (Lindquist et al., 1989). In addition,
most members of the LysR family require the presence
of inducing ligands for transcriptional activation of their
target genes (Schell, 1993).
At least two mechanisms could possibly account for
the intrinsic ability of purified AmpR to activate ampC
transcription: (i) The AmpR molecules, obtained by the
denaturation/renaturation procedure from the insoluble
fraction of the AmpR-overproducing cells, might some-
how have acquired a transcriptionally active conforma-
Figure 3. AmpR Activates ampC Transcription In Vitro without Addi- tion different from that of the native soluble AmpR. (ii)
tional Factors
In the bacterial cell, AmpR might be continously main-
(A) In vitro AmpR-mediated activation of ampC transcription and
tained in an inactive form by an endogenous negativerepression of ampR expression. Transcription assays were per-
ligand.formed in the presence of increasing AmpR concentrations (0, 8,
Genetic studies have shown that in Rhizobium meli-40, and 400 nM in lanes 1±4, respectively). Purified AmpR was prein-
cubated with DNA template prior to RNA polymerase addition. The loti, the molecular chaperone GroEL is required for regu-
resulting transcription product was divided into three samples and lation of nod genes by the transcriptional LysR-type
individually analyzed by reverse transcription using end-labeled regulator, NodD (Ogawa and Long, 1995), implying that
primers complementary to the ampC, tet, or ampR messages, re- the folding process per se can control induction of gene
spectively. Arrows indicate transcript extension products of 178,
expression. Therefore, rather than purifying AmpR from201, and 363 nt of ampC, tet, and ampR, respectively.
the insoluble fraction, which necessarily implies an in(B) AnhMurNAc-tripeptide has no effect on the activation of ampC
transcription mediated by AmpR-enriched extracts in vitro. In vitro vitro renaturation, the soluble fraction of the lysed
transcription assays were performed in the presence of AmpR- AmpR-overexpressing cells was used. Nucleic acids
enriched protein extracts (see Experimental Procedures) of 10 (lane and low molecular weight compounds were eliminated
1, 10x) and 1 mg/ml (lanes 2±4, x) of proteins in the presence of 130 by a procedure that maintained AmpR in its soluble
or 400 mM anhMurNAc-tripeptide (lanes 3 and 4, respectively), or
native form (see Experimental Procedures). When thisin the absence of anhMurNAc-tripeptide (lanes 1 and 2). Both end-
AmpR-enriched protein preparation was used in vitro,labeled primers complementary to ampC and tet were added to a
third of the transcript preparation and used to prime reverse tran- ampC transcription was stimulated in a concentration-
scription. dependent manner, in contrast to the expression of the
control tet gene (Figure 3B).
Addition of the anhMurNAc-tripeptide muropeptide to
Next, the ability of purified AmpR to regulate expres- a final concentration as high as its estimated concentra-
sion of ampC and ampR in defined in vitro transcription tion in a constitutive b-lactamase-overproducing ampD
assays was examined. AmpR was incubated with the mutant (0.4 mM) did not further activate ampC transcrip-
E. coli RNA polymerase holoenzyme and the pNU305 tion in the presence of either AmpR-enriched extracts
plasmid carrying ampR and ampC genes, as well as (Figure 3B) or purified AmpR (Figure 6). Thus, the ampC
the tetracycline resistance gene tet, which served as promoter apparently could be fully activated by AmpR
a control. To avoid titration by the multiple promoters in the absence of additional factors.
carried by the pNU305 plasmid, the RNA polymerase
was present in excess in the transcription mixtures. The
transcription products generated in vitro were then ex- The Cell Wall Precursor, UDP-MurNAc-Pentapeptide,
Represses Activation of ampC Transcriptionamined by primer extension assays. As shown in Figure
3A, there was nodetectable transcription from the ampC Mediated by Wild-Type AmpR but Not by
a Constitutive AmpR(G102E) Mutantpromoter in the absence of AmpR, but transcription from
the ampR promoter was significant. When the DNA tem- Induction of b-lactamase by the b-lactam antibiotic, cef-
oxitin, resulted both in a reduced pool level of the mainplate was incubated with increasing concentrations of
AmpR prior to the addition of RNA polymerase, the tran- cytoplasmic precursor of murein, UDP-MurNAc-penta-
peptide, and in an accumulation of recycled muropep-scription of ampC was strongly stimulated, while that
of ampR progressively decreased (Figure 3A). The addi- tides in the cytoplasm (Jacobs et al., 1994). UDP-Mur-
NAc-pentapeptide was therefore tested as a repressortion of AmpR had no significant effects on the control
tet gene expression (Figure 3A). The start sites of the for AmpR activation in the in vitro transcription assay.
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and constitutive b-lactamase expression in the absence
of b-lactam inducer in wild-type as well as in an ampG-
null mutant (Bartowsky and Normark, 1991; Normark et
al., 1994). Thus, the Gly102Glu replacement apparently
eliminates the sensitivity of AmpR to its putative li-
gand(s). If UDP-MurNAc-pentapeptide is a repressor for
AmpR activation in vivo, then the AmpR(G102E) mutant
mediating high constitutive ampC transcription should
not respond to the negative effect of UDP-MurNAc-
pentapeptide. Therefore, the ampR(G102E) gene was
cloned and its product purified as described for the wild-
type AmpR. After IPTG induction, AmpR(G102E) was
synthesized at a level similar to that of wild-type protein
(Figure 2, compare lane 3 to lane 2). In transcription
assays, purified AmpR(G102E) behaved as the wild-type
AmpR in the activation of ampC transcription. However,
increasing concentrations of UDP-MurNAc-pentapep-
tide failed to reduce the level of AmpR(G102E)-mediated
Figure 4. Repression of Wild-Type AmpR Activation by UDP-Mur- activation in contrast to what occurred with the wild-
NAc-Pentapeptide type protein (Figure 4B). This result clearly suggests
(A) Increasing concentrations of UDP-MurNAc-pentapeptide (0, 0.4, a regulatory role for UDP-MurNAc-pentapeptide in
and 0.8 mM; lanes 1, 2, and 3, respectively) were incubated with 40 b-lactamase induction. The murein precursor would
nM purified wild-type AmpR and DNA template prior to the addition
maintain the transcriptional activator AmpR in an inac-of RNA polymerase. Both end-labeled primers complementary to
tive form during normal growth conditions.ampC and tet were added to one third of the transcript preparation
and used to prime reverse transcription. Another third of the tran-
script preparation was analyzed by primer extension using a primer The DNaseI Footprint Caused by Wild-Typecomplementary to ampR (see Figure 3 legend).
AmpR Is Altered in the Presence(B) Increasing concentrations of UDP-MurNAc-pentapeptide of 0
of UDP-MurNAc-Pentapeptide(lanes 1 and 5), 0.15 (lanes 2 and 6), 0.3 (lanes 3 and 7), and 0.6 mM
(lanes 4 and 8) were incubated with either 40 nM purified wild-type The binding affinities of wild-type and mutant (G102E)
AmpR (lanes 1±4) or 40 nM purified AmpR(G102E) (lanes 5±8) and AmpR proteins for the ampC±ampR intergenic region
pNU305 DNA template prior to the addition of RNA polymerase. The (Figure 5A) were not affected by UDP-MurNAc-penta-
ampC transcript-extension product is shown. peptide, as determined by gel shift experiments (Figure
5B). The interactions between AmpR and its DNA-bind-
As seen inFigure 4A, the presence of increasing concen- ing region were therefore studied in more detail by per-
trations of UDP-MurNAc-pentapeptide considerably re- forming DNaseI protection assays on ampC±ampR
duced the AmpR-dependent activation of theampC pro- intergenic DNA. Purified wild-type AmpR and AmpR
moter, while transcription of the control tet gene was (G102E) gave rise to identical footprints. In each case,
increased with higher concentrations of UDP-MurNAc- a footprint of 39 nt for the ampC-transcribed strand
pentapeptide. Consistently, an increase in the synthesis (Figure 5C, bottom) and 48 nt for the ampR-transcribed
of any tested gene (except for ampC) was observed in strand (Figure 5C, top) was found. Footprints by wild-
transcription mixtures containing UDP-MurNAc-penta- type AmpR and AmpR(G102E) required the same protein
peptide, even in the absence of AmpR. This unspecific concentrations. The presence of UDP-MurNAc-penta-
increase of expression is likely due to the multiple nega- peptide in the binding buffer resulted in a small but
tive charges of UDP-MurNAc-pentapeptide at neutral consistent alteration in the protection pattern by wild-
pH, which might provide an ionic environment favoring type AmpR butnot by AmpR(G102E) (Figure 5D). Specifi-
RNA polymerase activity. cally, the base in position 249 (relative to the 11 tran-
The activity of the ampR promoter did not decrease in scription start-site of ampC) was no longer protected
the presence of UDP-MurNAc-pentapeptide, but rather on the bottom strand by wild-type AmpR in the presence
unspecifically increased, as did that of the control tet of UDP-MurNAc-pentapeptide (Figure 5A). This addi-
gene (Figure 4A). This activity was consistent with the tional protected base was closest to the ampC pro-
observation that expression of an ampR±lacZ transcrip-
moter. These results provide further evidence that UDP-
tional fusion is not influenced by the presence of
MurNAc-pentapeptide alters transcription activation of
b-lactam inducers (Lindquist et al., 1989). Therefore,
ampC through AmpR.
UDP-MurNAc-pentapeptide only specifically affects
ampC transcription by reducing AmpR-dependent acti-
Displacement of the Repressingvation. The other main murein precursor, UDP-GlcNAc,
UDP-MurNAc-Pentapeptide by thehad no effect on the transcription reactions (data not
anhMurNAc-Tripeptide Resultsshown).
in AmpR ActivationThe physiological significance of the UDP-MurNAc-
The existence of a repressing ligand for AmpR is notpentapeptide effect in b-lactamase inductionwas inves-
sufficient to explain induction of ampC transcription, astigated by using the properties of an AmpR(G102E)
evidenced by the fact that the decrease of the poolmutant. Expressionof this mutant protein in the reconsti-
tuted E. coli system and in C. freundii results in a high of UDP-MurNAc-pentapeptide caused by cefoxitin was
b-Lactam Resistance and Cell Wall Metabolism
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Figure 5. Effects of the Presence of UDP-MurNAc-Pentapeptide on Wild-Type and Mutant (G102E) AmpR±DNA Interactions
(A) The ampC±ampR intergenic region. The 11, 210, and 235 sites for ampC and for ampR are indicated below and above the DNA sequence,
respectively. Arrows represent the direction of transcription from each promoter. DNaseI sites protected by AmpR in the absence of UDP-
MurNAc-pentapeptide are indicated by horizontal bars. The solid triangle shows the position of the base that loses its DNaseI protection on
the bottom strand in the presence of UDP-MurNAc-pentapeptide.
(B) Gel shift mobility assays. The 290 bp fragment containing the ampC±ampR intergenic region was PCR-labeled and incubated with increasing
concentrations of wild-type AmpR (lane 1, no AmpR; lanes 2 and 3, 10 nM; lanes 6 and 7, 50 nM) or AmpR(G102E) (lanes 4 and 5, 10 nM;
lanes 8 and 9, 50 nM) in the absence (lanes 1, 2, 4, 6, and 8) or presence (lanes 3, 5, 7, and 9) of 0.4 mM UDP-MurNAc-pentapeptide. The
position of the free 290 bp DNA fragment (f) and of the gel-retarded AmpR-DNA complex (c) are indicated by arrowheads.
(C) DNaseI-protection assay by AmpR. The 290 bp fragment containing the ampC±ampR intergenic region was end-labeled on the ampR-
transcribed strand (top; lanes 1±4) or the ampC-transcribed strand (bottom; lanes 5±8) and incubated with decreasing concentrations of AmpR
(lanes 1 and 5, 300 nM; lanes 2 and 6, 100 nM; lanes 3 and 7, 20 nM; lanes 4 and 8, no AmpR). DNaseI-protected sites are indicated by
vertical bars. Positions of bases relative to the 11 transcription start of ampC are indicated. T, G, C, and A indicate the sequence markers.
(D) DNaseI-protection assay by wild-type AmpR and AmpR(G102E) in the presence and absence of UDP-MurNAc-pentapeptide. The 290 bp
fragment containing the ampC±ampR intergenic region was end-labeled on the ampC-transcribed strand and incubated with 200 nM wild-
type AmpR (lanes 1 and 5) or with 200 nM AmpR(G102E) (lanes 2 and 6), or with no AmpR (lanes 3 and 4), in the absence (lanes 4±6) or
presence (lanes 1±3) of 0.4 mM UDP-MurNAc-pentapeptide. Positions of bases relative to the 11 transcription start of ampC are also indicated.
also observed in an ampG mutant in which no induction reversed the negative effect of UDP-MurNAc-pentapep-
tide on ampC transcription (Figure 6) but had no effectof b-lactamase expression occurs (Jacobs et al., 1994).
Moreover, an ampD mutant that constitutively overex- on the level of AmpR-dependent activation of ampC
transcription in the absence of UDP-MurNAc-pentapep-presses b-lactamase has a normal level of UDP-Mur-
NAc-pentapeptide (C. J. and D. Mengin-Lecreulx, un- tide. In no case was the transcription level of the control
gene altered (data not shown). Thus, the anhMurNAc-published data) but exhibits a dramatically increased
cytosolic concentration of the murein metabolite anh- tripeptide acts as a competitor of the repressing mole-
cule. A mixture of GlcNAc-anhMurNAc-tetrapeptideMurNAc-tripeptide (Jacobs et al., 1994). It was therefore
hypothesized that high concentrations of anhMurNAc- and -tripeptide (3:1), the usual muropeptides resulting
from transglycosylase and endopeptidase degradationtripeptide could displace the repressing UDP-MurNAc-
pentapeptide from its AmpR-binding site. In the tran- of murein in E. coli, could not replace the anhMurNAc-
tripeptide as anti-repressor (data not shown).scription assays, anhMurNAc-tripeptide consistently
Cell
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repressed state. In general, ligands interacting with
members of the LysR family do not greatly affect the
binding activity of the proteins to their operator se-
quences (Schell, 1993).
High concentrations of anhMurNAc-tripeptide, similar
to that found in ampD mutants that constitutively over-
produce b-lactamase (Jacobs et al., 1994), alleviate the
repression of AmpR by UDP-MurNAc-pentapeptide in
Figure 6. In Vitro Competition between UDP-MurNAc-Pentapeptide vitro, but have no effect on AmpR-dependent transcrip-
and anhMurNAc-Tripeptide for AmpR Activation
tion of ampC in the absence of UDP-MurNAc-penta-
In vitro transcription mixtures containing 10 nM wild-type AmpR
peptide.were preincubated under the following conditions prior to the addi-
Based on these findings, the transcriptional activationtion of RNA polymerase: lane 1, no addition; lane 2, 0.3 mM UDP-
of the ampC b-lactamase gene in response to eitherMurNAc-pentapeptide; lane 3, 0.35 mM anhMurNAc-tripeptide; lane
4, 0.3 mM UDP-MurNAc-pentapeptide and 0.35 mM anhMurNAc- b-lactam antibiotics or ampD mutations can be ex-
tripeptide. The ampC transcript extension product is shown. plained as described by Figure 7. During normal growth
in the absence of b-lactam inducers, the AmpR regulator
expressed in wild-type cells is maintained in an inactive
Discussion form by theUDP-MurNAc-pentapeptide (Figure 7A). This
negative effect likely occurs by direct binding of UDP-
We describe here an inducible bacterial defense mecha- MurNAc-pentapeptide to the regulator, since the single-
nism against b-lactam antibiotics that is oppositely point mutation Gly102Glu suppresses this negative
controlled by the cytoplasmic concentrations of bio- effect and leads to constitutive activation of the trans-
synthetic and degradative intermediates of murein criptional regulator. In this inactive form, AmpR binds
metabolism. This system thus operates as a cell±wall to its operator site, leading to a repression of ampR
sensing device. transcription and an absence of activation of the ampC
The in vitro transcription experiments showed that promoter. This inactivation of AmpR can be relieved by
wild-type AmpR negatively regulates transcription at its both knockout mutations in the ampD gene and the
own promoter gene as it does in vivo. But, in contrast presence of b-lactam antibiotics in the culture medium.
to the in vivo situation, the mere presence of AmpR Inactivation of ampD, which encodes a cytosolic ami-
greatly enhances ampC transcription in a concentration- dase specific for the recycling of muropeptides, results
dependent fashion. Purified AmpR(G102E), which is in a drastic accumulation of its substrate, the anhMur-
known to derepress constituitively b-lactamase expres- NAc-tripeptide. The high concentration of this muropep-
sion in vivo (Bartowsky and Normark, 1991), exhibits a tide inside the cell is sufficient to displace the UDP-
similar effect. Thus, outside the cellular context, AmpR MurNAc-pentapeptide from its AmpR-binding site,
functions as an efficient activator for ampC b-lactamase thereby reactivating AmpR (Figure 7B). In wild-type
transcription without an additional factor(s). The in vitro± cells, addition of a b-lactam inducer, such as cefoxitin,
activating properties of wild-type AmpR at the ampC results in increased production of cell±wall degradation
promoter are specifically decreased by increasing con- fragments and, consequently, in a higher intracellular
centrations of UDP-MurNAc-pentapeptide. The concen- level of anhMurNac-tripeptide by titrating the available
trations of UDP-MurNAc-pentapeptide used in the in AmpD activity. However, the level of anhMurNac-tripep-
vitro assays were similar to that estimated in the cell tide in b-lactam-induced cells is considerably lower than
(between 0.2 and 0.6 mM; Mengin-Lecreulx et al., 1982, in ampD mutants. This is compensated for by a de-
1989), which identifies this murein precursor as a re- creasedpool levelof UDP-MurNAc-pentapeptide, a sec-
pressing ligand for AmpR activation. In addition, the ond consequence of exposure to cefoxitin. Small in-
repressive effect of UDP-MurNAc-pentapeptide was creases of anhMurNAc-tripeptide and decreases of
shown to be AmpR-mediated, since the activation at UDP-MurNAc-pentapeptide levels could act in a con-
the ampC promoter by AmpR(G102E) is not affected in certed way to displace the UDP-MurNAc-pentapeptide
the presence of this murein precursor. Moreover, UDP- repressor from AmpR, resulting in activation of b-lacta-
MurNAc-pentapeptide modifies wild-type AmpR con- mase expression (Figure 7C).
tacts with its DNA-binding region, but has no effect on Inhibitory compounds have been described for other
AmpR(G102E)-DNA interactions. UDP-MurNAc-penta- members of the LysR family, such as NodD (Djordjevic
peptide causes wild-type AmpR to alter its contacts with et al., 1987) and CysB (Ostrowski and Kredich, 1990).
the ampC-transcribed strand at the extremity closest to Both NodD and CysB, however, activate transcription
the 235 region of the ampC promoter, perhaps leading of their regulated genes only in the presence of their
to the impairement of positive interaction with the RNA respective coinducer, and the inhibitory compounds af-
polymerase. The DNaseI-protected region close to the fect the stimulatory activity of the coinducer. Thus, in
ampR gene is unaffected by the presence of UDP-Mur- both cases, the inhibitory compounds act as anti-
NAc-pentapeptide, in agreement with the fact that ampR inducers that suppress the inducer-mediated activation
transcription does not respond to b-lactam inducers in of either NodD or CysB by competition. In the AmpR
vivo (Lindquist et al., 1989). DNA gel shift experiments system, the UDP-MurNAc-pentapeptide acts as a re-
showed that UDP-MurNAc-pentapeptide did not affect pressor for a protein that is intrinsically active, and the
the affinity of AmpR for its operator region. Thus, AmpR anti-repressor anhMurNAc-tripeptide displaces the re-
pressor molecule, restoring the native activity of AmpR.also binds to the ampC±ampR intergenic region in its
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Figure 7. Model for AmpC b-lactamase Induction
GlcaMurTp, aMurTp, Tp, UDPGlc, UDPMur, and UDPMurPp are abbreviations for GlcNAc-anhMurNAc-tripeptide, anhMurNAc-tripeptide,
tripeptide, UDP-GlcNAc, UDP-MurNAc, and UDP-MurNAc-pentapeptide, respectively. AmpRI indicates the transcriptionally inactive form of
AmpR; AmpRA indicates the transcriptionally active form of AmpR. Vertical arrows next to UDPMurPp and aMurTp illustrate the intensity and
the direction of pool size variations for UDP-MurNAc-pentapeptide and anhMurNAc-tripeptide, respectively. The larger arrowheads in (C)
indicate higher entry of muropeptides. (A) Wild-type cells during normal growth conditions. (B) ampD mutants blocked in murein recycling.
(C) Wild-type cells when exposed to a b-lactam antibiotic inducer, such as cefoxitin.
The regulation by two ligands rather than one can be cell cycle. Mechanisms that would continously monitor
understood in terms of a need for signal amplification the cell wall status would be useful for ensuring appro-
and greater flexibility. It circumvents the constraint of priate morphological responses. b-lactamase induction
sensing the levelof endogenoussignal molecules whose might be one example of a transcriptional response to
range of pool size variations is narrow. In that respect, alterations in the intracellular level of murein metabo-
the AmpR system is quite different from the other known lites, allowing the cell to respond to modifications in the
bacterial regulatory systems. In E. coli cells grown under cell wall metabolism. It has been shown that murein
normal conditions, the UDP-MurNAc-pentapeptide sat- hydrolase activity and murein synthesis vary during the
urates the translocase that catalyzes the first membrane growth cycle of E. coli (Beck and Park, 1976; Hakenbeck
reaction, since the cytoplasmic concentration (.1024 M) and Messer, 1977; Hinks et al., 1978; Olijhoek et al.,
(Mengin-Lecreulx et al., 1982) is higher than the Km value 1982). These observations suggest that the cytosolic
of the enzyme (Km 5 1025; Geis and Plapp, 1978). This concentrations of intermediates of murein biosynthesis
means that small variations of this precursor concentra- and recycling fluctuate during the bacterial cell cycle.
tion have no major effects on murein synthesis. How- In E. coli, moreover, the pool levels of both nucleotide
ever, an important decrease of this concentration, i.e., to precursors UDP-GlcNAc and UDP-MurNAc-pentapep-
below the Km value, would certainly result in detrimental tide increase after inhibition of protein synthesis (Men-
consequences by slowing down murein biosynthesis. gin-Lecreulx et al., 1989), illustrating a link between mu-
Similarly, a large increase of the anhMurNAc-tripeptide rein and protein syntheses. It is thus possible that, like
level in wild-type cells would reflect an increased murein AmpR, other transcriptional regulators control gene ex-
degradation that might result in osmotic lysis. A regula- pression by sensing small variations in the levels of
tory system sensitive to the concentrations of two li- intermediates of murein metabolism.
gands would be responsive to even smaller but simulta-
neous variations of their concentration. Additionally, it
Experimental Procedureswould allow a reduction of undesirable transcriptional
activity if the level of only one ligand were to be moder-
Chemicals
ately altered. AnhMurNAc-tripeptide was purified from E. coli JRG582 (Jacobs
The other main murein precursor, UDP-GlcNAc, has et al., 1994). Samples of GlcNAc-anhMurNAc-peptides were kindly
no effect on AmpR activation. Since UDP-GlcNAc is also provided by Dr. R. Rosenthal (Indianapolis, IN) andthe mureinuridine
precursors by Dr. J. van Heijenoort (Paris-Orsay, France) and Dr. P.a precursor for the syntheses of lipopolysaccharides
Reynolds (Cambridge, UK).and enterobacterial antigens (Raetz, 1996), any regula-
tion at this point might affect the syntheses of these
Cloning of the C. freundii Wild-Type and Mutantouter membrane molecules. A regulatory role for the
(G102E) Genes of ampR in an Expression Vectorother nucleotide precursors between UDP-GlcNAc and
The C. freundii ampR gene was cloned in the expression vectorUDP-MurNAc-pentapeptide is unlikely, since they are
pET-9a (Studier et al., 1990) by polymerase chain reaction (PCR)not at saturating concentrations for the enzymes that
with primers 59-(T)15GGATCCGTACATGCGTTAATTATCAGGCCCGutilize them (Mengin-Lecreulx et al., 1982). CTATT-39 and 59-(T)20CATATGGTACATGCGTTAATTATCAGGCCCG
Cell growth, division, and septation imply a delicate CTATT-39, and pNU305, which carries the C. freundii ampR gene as
coordination between murein synthesis and degrada- DNA template (Lindberg et al., 1985), using the procedures de-
scribed in Innis et al., 1990. Amplification yielded a DNA fragmenttion, and other metabolic processes during the bacterial
Cell
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containing the entire ampR coding sequence flanked on the 59 and was centrifuged and the supernatant containing the minor soluble
fraction of overexpressed AmpR was dialyzed against 20 mM so-39 ends by NdeI and BamHI restriction sites, respectively. This PCR
fragment was digested by NdeI and partially digested by BamHI, dium phosphate buffer (pH 7) containing 0.2 M NaCl and 1 mM DTT.
In order to remove nucleic acids, the dialysate was loaded onto asince the ampR sequence contains a BamHI restriction site. The
NdeI-BamHI fragment containing the entire ampR-coding sequence Mono-Q-Sepharose column equilibrated with the same buffer. Most
proteins, including AmpR, were directly recovered in the dead vol-was cloned into pET-9a, and the final construct (pCJ2) was propa-
gated in E. coli HMS174 (Studier et al., 1990). The ampR insert of ume of the column, whereas nucleic acids and very acidic proteins
remained bound to the exchanger. The AmpR-enriched solution wasplasmid pCJ2 was checked for mutations by sequencing both
strands (Sanger et al., 1977). The ampR(G102E) gene was similarly dialyzed against buffer B and concentrated to a final total protein
concentration of 0.5 mg/ml.cloned with plasmid pNU549 (Bartowsky and Normark, 1991) as
DNA template for PCR amplification. The resulting plasmid was
pCJ3. In Vitro Transcription
The in vitro transcription assay contained 3 nM pNU305 in the tran-
Expression and Purification of Wild-Type and Mutant scription buffer (40 mM Tris-HCl [pH 7.9], 150 mM KCl, 1 mM DTT,
(G102E) Forms of AmpR Protein 8 mM MgCl2, 5% glycerol) and different concentrations of AmpR
AmpR synthesis was induced at an A600 value of 1 by the addition and/or protein extract and/or murein metabolite as mentioned in
of 0.4 mM IPTG to a 1 liter culture of E. coli BL21(DE3) cells (Studier the Figures. The transcription mixture was incubated for 7 min at
et al., 1990) harboring pCJ2 after growth at 378C in LB medium 378C. Then, 1 ml of a 16 mM solution of RNA polymerase holoenzyme
containing 50 mg/ml of kanamycin. Cells were harvested after 2 hr, (Pharmacia) was added, and incubation continued for 10 min at
washed with 150 mM NaCl solution, and resuspended in 40 ml of 378C. The volume of the reaction sample was then 14.5 ml. After the
20 mM Tris-HCl buffer (pH 8) (buffer A). The cells were lysed by 2 addition of 0.5 ml of a 25 mM NTP mixture, the mixture was further
passages through a French press at 110 MPa. Most of the overpro- incubated for 15 min at 378C. The DNA template was then digested
duced AmpR protein was found in the insoluble fraction of the cellu- by DNaseI (Promega) for 30 min at 378C. After addition of 1 ml of
lar extract. After centrifugation (20,000 3 g, 25 min), the aggregates tRNA (10 mg/ml) and 84 ml of H2O, the nucleic acids were extracted
were solubilized in 10 ml of 2 M guanidine/HCl (GdnHCl) Tris-HCl with an equal volume of phenol:chloroform (1:1). After centrifugation
buffer (pH 8). The suspension was centrifuged (20,000 3 g, 25 min) through a Sephadex G50 spin column (Pharmacia), the nucleic acids
and the supernatant dialyzed against 5 l of 20 mM Tris-HCl buffer were ethanol-precipitated and resuspended in 10 ml of H2O. The
(pH 8), containing 0.5 M NaCl, 1 mM dithiothreitol (DTT), and 10% oligonucleotides 59-GCCTGCTCCTGCATCAGTGGTGTG-39, 59-CGG
glycerol (buffer B) in which AmpR remained soluble. AmpR was ACAGTGCTCCGAGAACGGGTGC-39, and 59-CAGCGGGAAAAGAC
subsequently precipitated by dialysis against buffer A containing AGCCGA-39, complementary to the ampC, tet, or ampR transcripts,
only 0.05 M NaCl. The precipitate was resolubilized in 2 M GdnHCl respectively, were end-labeled using [g-32P]ATP and T4 polynucleo-
and the proteins renatured by dialysis against 20 mM buffer B. The tide kinase (Maxam and Gilbert, 1980). Three microliters of the RNA
dialysate was then centrifuged and the supernatant loaded onto a preparation was hybridized with these 32P-end-labeled oligonucleo-
molecular sieve chromatography column (Superose 12 HR 10/30) tides. After addition of AMVreverse transcriptase (Boehringer Mann-
equilibrated with buffer B and eluted at a flow rate of 0.5 ml/min. heim), half of the labeled extension transcript products were size-
Fractions containing AmpR were identified by gel shift assay and fractionated using a denaturating 6% polyacrylamide 7 M urea gel.
SDS±PAGE, pooled, concentrated to a final concentration of 0.5 After drying, radioactive bands were examined with the help of the
mg/ml, and stored at 2208C. This procedure is similar to that de- PhosphorImager and analyzed with the ImageQuant program. The
scribed by Bishop and Weiner (1993). expected transcript extension products of ampC, tet, and ampR
AmpR(G102E) was purified from IPTG-induced E. coli BL21(DE3) were 178, 201, and 363 nt in length, respectively.
cells harboring pCJ3 by the same procedure, but the purified protein
was stored at 48C to avoid precipitation. Protein concentrations
DNaseI Protection Analysiswere determined by the Coomassie blue assay (Bradford, 1976).
A 290 bp PCR amplification product containing the ampC±ampR
intergenic region was synthesized according to Innis et al. (1990).Determination of the Active Fraction of the Purified
The oligonucleotides 59-GAGGCTGTCAGCAGCAGC-39 and 59-GGCAmpR Preparation
TGATGGCAGAATTGCG-39 were used to prime DNA synthesis, andLarge quantities of a biotinylated 80 bp DNA fragment harboring
plasmid pNU305 was used as a template. The PCR product wasthe AmpR-specific recognition sequence were produced by a scale-
strand-specifically labeled by previously labeling one of the twoup PCR using the plasmid pNU305 as DNA template and primers
oligonucleotides with [g-32P]ATPand T4 polynucleotide kinase.DNa-59-biotin-TGATTTGCACCGTGTTG and 59-GCTACGCGTCATCATT.
seI digestions were carried out using 0.5 pmol of labeled DNA frag-After removal of unincorporated 59-biotinylated primers by using a
ment and AmpR, as described in the legend to Figure 5, in 10 mMPCR purification kit (QIAGEN), 4.8 nmol of the biotinylated 80 bp
Tris-HCl buffer (pH 7.9) containing 4 mM MgCl2, 50 mM NaCl, andDNA fragment was coupled to 8 mg of magnetic Dynabeads M-280
5% glycerol. Where indicated, UDP-MurNAc-pentapeptide wasstreptavidin (Dynal A/S), following the procedure recommended by
added to a final concentration of 400 mM. Digestion was initiatedthe manufacturer. Seventy-five nanograms of purified AmpR was
by the addition of 0.05or 0.005 U of DNaseI (Promega) in the absenceincubated with the resulting DNA affinity beads (the final concentra-
or presence of UDP-MurNAc-pentapeptide, respectively. UDP-tion of DNA being 24 mM) in 10 mM Tris-HCl buffer (pH 7.5) containing
MurNAc-pentapeptide generally improved in vitro transcription.1 mM EDTA and 50 mM NaCl for 10 min at room temperature. In a
Likewise, the DNaseI activity was increased 103 when UDP-control, 75 ng of purified AmpR was also incubated in the same
MurNAc-pentapeptide was added to the DNaseI-footprinting reac-conditions with 8 mg of beads that had not been coupled to DNA.
tions. The reaction mixtures were incubated for 2 min at room tem-AmpR protein bound to the beads was separated from free proteins
perature, and the reactions were stopped by addition of ice-coldby using a magnetic particle concentrator (Dynal A/S). The beads
H2O and an equal volume of phenol:chloroform (1:1). The nucleicwere then washed by resuspension and magnetic separation in the
acids were then speedvac-dried, resuspended in loading buffersame Tris-HCl buffer. AmpR protein was eluted after resuspension
(80% [v/v] formamide, 50 mM Tris-HCl [pH 8], 1 mM EDTA, 0.1% [w/and magnetic separation of the DNA affinity beads in 10 mM Tris-
v] xylen cyanol, 0.1%[w/v] bromophenol blue),and size-fractionatedHCl buffer (pH 7.5) containing 1 mM EDTA and 2 M NaCl. Each
using a denaturating 6% polyacrylamide 7 M urea gel. After drying,eluate was analyzed for its AmpR content by Western blotting using
radioactive bands were examined as above. A dideoxy sequencingpolyclonal anti-AmpR antibodies, the BM chemiluminescence blot-
reaction (Sanger et al., 1977) carried out with the same oligonucleo-ting substrate (POD) (Boehringer Mannheim), and anti-rabbit IgG-
tides was used as standard.POD (Boehringer Mannheim) for detection (Gallagher, 1995).
Gel-Shift AnalysisPreparation of AmpR-Enriched Extracts
The DNA-binding assay was performed as previously describedIPTG-induced E. coli BL21(DE3) cells (250 ml culture) harboring
pCJ2 were harvested and lysed as described above. The lysate by Bartowsky and Normark (1991). The 290 bp PCR amplification
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product described above was labeled during the synthesis process Innis, M.A., Gelfond, D.H., Snisky, J.J., and White, T.J. (1990). PCR
Protocols, a Guide to Methods and Applications (New York: Aca-by incorporating [a-35S]dATP. Wild-type and mutant (G102E) AmpR
were added to final concentrations, described in the legend of Figure demic Press).
5B, in 10 mM Tris-HCl buffer (pH 7.9) containing 4 mM MgCl2 and Jacobs, C., Huang, L.-J., Bartowsky, E., Normark, S., and Park, J.T.
75 mM NaCl. Where indicated, UDP-MurNAc-pentapeptide was (1994). Bacterial cell wall recycling provides cytosolic muropeptides
added to a final concentration of 400 mM. as effectors for b-lactamase induction. EMBO J. 13, 4684±4694.
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